Related by context. All words. (Click for frequent words.) 74 Abatacept 74 Natalizumab 74 Tiotropium 74 Pemetrexed 73 Prolongs Survival 73 Golimumab 73 Teriparatide 73 Adalimumab 73 Alemtuzumab 73 Dasatinib 72 efalizumab 72 Meets Primary Endpoint 72 Nilotinib 72 Lamotrigine 72 Allergic Rhinitis 72 Degarelix 72 Ustekinumab 72 alefacept 72 Pulmonary Arterial Hypertension 72 Decitabine 72 Complicated Skin 72 Lubiprostone 72 Glatiramer Acetate 72 Bevacizumab 72 Anti TNF 72 Oral Fingolimod 72 Relapsing Multiple Sclerosis 72 TNF Tumor Necrosis Factor 72 Lenalidomide 71 ZOLINZA 71 INTEGRILIN R 71 Long Term Efficacy 71 Diabetic Neuropathy 71 Severe Asthma 71 adalimumab Humira 71 Chronic Myeloid Leukemia 71 Overactive Bladder 71 Romiplostim 71 Aliskiren 71 Mycophenolate Mofetil 71 metastatic malignant 71 Zorbtive TM 71 Bortezomib 71 Tocilizumab 71 Traficet EN 71 Psoriatic Arthritis 71 Fingolimod 71 relapsing multiple sclerosis 71 Zoledronic acid 71 PKC# 71 Ziprasidone 71 Paraplatin ® 71 Plaque Psoriasis 71 Myelodysplastic Syndrome MDS 70 Investigational Treatment 70 Severe Sepsis 70 thalidomide Thalomid 70 Atomoxetine 70 Platinol ® 70 tocilizumab 70 Malignant Glioma 70 RAPTIVA 70 Demonstrates Efficacy 70 Epoetin Alfa 70 Rituximab 70 Eltrombopag 70 ACE Inhibitors 70 Juvenile Idiopathic Arthritis 70 Investigational Compound 70 Previously Treated 70 Adjuvant Treatment 70 Bipolar Mania 70 Patients Receiving 70 Betaferon R 70 Certolizumab 70 cinacalcet 70 icatibant 70 Pivotal Phase III 70 Rheumatoid Arthritis Patients 70 SPRYCEL ® 69 Newly Diagnosed Multiple Myeloma 69 Infliximab 69 Pirfenidone 69 Omalizumab 69 Antitumor Activity 69 Interferon Beta 69 Interferon beta 1a 69 Vandetanib 69 JAK Inhibitor 69 Risperidone 69 Cimzia ® certolizumab pegol 69 Psoriasis Drug 69 Vidaza azacitidine 69 Gemzar ® 69 Kepivance 69 FASLODEX 69 Myelodysplastic Syndrome 69 Pioglitazone 69 Lupus Nephritis 69 hypereosinophilic syndrome 69 Eculizumab 69 Neovascular Age Related Macular 69 ORENCIA R 69 Relapsed Refractory 69 briakinumab 69 Advanced Melanoma 69 Leukemias 69 Monotherapy 69 Rilonacept 69 Gemcitabine 69 Mg Usa 69 PEGylated anti 69 ACTEMRA TM 69 ULORIC 69 Teriflunomide 69 Treated Patients 69 gefitinib Iressa 69 Inhalation Solution 69 basiliximab 69 Antipsychotic 69 RoACTEMRA 69 Myelofibrosis 69 Fludarabine 69 Subgroup Analysis 69 Well Tolerated 69 Pertuzumab 69 Boceprevir 69 beta 1a 69 juvenile idiopathic arthritis 69 Community Acquired Pneumonia 69 Efficacious 69 Patients Treated With 69 PROCRIT ® 69 Atypical Hemolytic Uremic Syndrome 69 Bronchiectasis 69 canakinumab 69 Adjuvant Chemotherapy 69 Cimzia certolizumab pegol 69 Vaprisol 69 CIMZIA R 69 Fulvestrant 69 PEGylated Fab fragment 68 STELARA TM 68 Adjunctive Therapy 68 Fabry Disease 68 Bosutinib 68 Parnate 68 Tacrolimus 68 Combo Therapy 68 Trastuzumab 68 Aflibercept 68 Rotigotine 68 Fondaparinux 68 Epratuzumab 68 Ranolazine 68 Catena ® 68 Torisel 68 Sprycel dasatinib 68 Zileuton 68 Chronic Sinusitis 68 Phase IIb Trial 68 etanercept Enbrel 68 Montelukast 68 Noxafil 68 Bicalutamide 68 Anti VEGF 68 Desvenlafaxine 68 omalizumab Xolair 68 Remicade infliximab 68 Inhalation Aerosol 68 Belimumab 68 Sycrest 68 5 Fluorouracil 68 TEMODAL 68 dual endothelin receptor antagonist 68 candesartan cilexetil 68 Disease Progression 68 ARIXTRA R 68 visilizumab 68 NDA Submission 68 Cinacalcet 68 See CLINICAL PHARMACOLOGY 68 Roche Actemra 68 systemic corticosteroid 68 chronic immune thrombocytopenic 68 VAPRISOL 68 somatostatin analog 68 Certolizumab pegol 68 Renal Anemia 68 Fludara ® 68 Everolimus 68 adalimumab 68 AVONEX ® 68 Study Evaluating 68 Peginterferon 68 colesevelam HCl 68 Pregabalin 68 biologic therapy 68 Cyclooxygenase 2 68 Eszopiclone 68 Ischemic 68 Ramelteon 68 selective modulator 68 Major Depressive Disorder 68 Hormone Refractory Prostate Cancer 68 infliximab Remicade 68 Cutaneous T 68 Treatment Resistant 68 Capecitabine 68 Acute Bacterial Sinusitis ABS 68 PsA 68 familial amyloidotic polyneuropathy FAP 68 Ranibizumab 68 Capsules CII 68 Double Blind Randomized 68 formerly LymphoStat B 68 juvenile idiopathic arthritis JIA 68 Methylnaltrexone 68 Levofloxacin 68 Aripiprazole 68 ankylosing spondylitis psoriatic arthritis 68 Pharmacokinetics PK 68 Humira adalimumab 68 Calcitonin 68 Actonel risedronate 68 Single Dose 68 Tipranavir 68 ara C 68 CYT# QbG# 68 aripiprazole Abilify 68 Systemic lupus erythematosus SLE 68 Orphan Status 68 Shows Efficacy 68 rufinamide 68 rituximab Rituxan 68 Relapsing Remitting Multiple Sclerosis 68 Bazedoxifene 68 Hepatotoxicity 68 chronic idiopathic thrombocytopenic purpura 68 First Patient Dosed 68 Hypercholesterolemia 68 Corticosteroids 68 Tyrosine Kinase Inhibitor 68 Bucindolol 68 Sandostatin R 68 Cyclophosphamide 68 nilotinib Tasigna 68 Melphalan 68 Increlex ® 68 atypical Hemolytic Uremic Syndrome 68 Phase III Clinical Trial 68 Relapsed Multiple Myeloma 68 Soft Tissue Sarcoma 68 relapsed MM 67 Phase 2b Study 67 Eraxis 67 SEROQUEL R 67 Pooled Analysis 67 Randomized Double blind 67 Vimpat R 67 chronic eosinophilic leukemia 67 Naive Patients 67 Diabetic Neuropathic Pain 67 Vidofludimus 67 ORENCIA ® 67 Valsartan 67 Tumor Necrosis Factor 67 Mg Uk 67 diabetic gastroparesis 67 primary Restless Legs 67 Slows Progression 67 Bosentan 67 Angiotensin Converting Enzyme 67 Metastatic Colorectal Cancer 67 Improves Outcomes 67 Inhaled Corticosteroids 67 leukotriene receptor antagonist 67 Demonstrate Significant 67 sorafenib tablets 67 Denufosol 67 Cyclosporine 67 Secondary Hyperparathyroidism 67 alfa 2a 67 Zoledronic Acid 67 Perforomist ™ Inhalation Solution 67 STELARA ™ 67 Idiopathic Pulmonary Fibrosis 67 purpura ITP 67 Dapagliflozin 67 galiximab 67 azacitidine 67 Acute Ischemic Stroke 67 Posaconazole 67 chronic granulomatous disease 67 YONDELIS 67 CIMZIA ™ 67 Follicular Lymphoma 67 Treatment Naive Patients 67 Teva Provides Update 67 Granted Orphan Drug 67 Neoadjuvant 67 R adalimumab 67 levocetirizine 67 Fluconazole 67 Chronic Heart Failure 67 Laquinimod 67 Risedronate 67 Moxifloxacin 67 active ankylosing spondylitis 67 sertraline Zoloft 67 Recombinant Human 67 Interferon alpha 67 Cimzia TM 67 ACZ# 67 Investigational Agent 67 Shows Promise Against 67 Enlarged Prostate 67 Interferon beta 67 HCV Protease Inhibitor 67 Nebulized 67 Benign Prostatic Hyperplasia 67 Febuxostat 67 Zarnestra 67 Taxol ® 67 Hsp# Inhibitor 67 CYT# potent vascular disrupting 67 systemic juvenile idiopathic 67 Anthracycline 67 Icatibant 67 Vildagliptin 67 Xyrem ® 67 INCB# [003] 67 Taxotere ® 67 eosinophilic asthma 67 Treating Chronic 67 Phase III Trial 67 Topiramate 67 Renal Cell Carcinoma 67 Efficacy Trial 67 Campath alemtuzumab 67 Sipuleucel T 67 Phase 2b Trial 67 Knee Osteoarthritis 67 Investigational Drug 67 rFVIIa 67 PENTASA 67 Combination Therapy 67 HeFH 67 Immunosuppressant 67 Growth Hormone Deficiency 67 Darunavir 67 Aviptadil 67 Peginterferon alfa 2b 67 rotigotine transdermal patch 67 riociguat 67 Alvesco R 67 Survival Benefit 67 retinal vein occlusion 67 LEUKINE 67 Pegloticase 67 Increlex R 67 Oral Formulation 67 invasive candidiasis 67 Proleukin 67 RhuDex 67 Improves Survival 67 Kidney Transplant Patients 67 Indomethacin 67 Non Alcoholic Steatohepatitis 67 DOXIL 67 Epidermal Growth Factor Receptor 67 CIMZIA TM 67 vapreotide acetate 67 Kuvan sapropterin dihydrochloride 67 Myelodysplastic Syndromes 67 Chronic Lymphocytic Leukemia 67 levetiracetam Keppra 67 Pemphigus 67 Tolvaptan 67 glatiramer acetate 67 mycophenolate mofetil 67 IRESSA 67 Galantamine 67 Irinotecan 67 Tasigna nilotinib 67 Lambert Eaton Myasthenic 67 PRIALT 67 Phase IIb Clinical Trial 67 Temsirolimus 67 Treat Anemia 67 Refractory Hodgkin Lymphoma 67 Dupuytren Contracture 67 Patients Treated 67 Acute Decompensated Heart Failure 67 Ischaemic 67 Safinamide 67 Phase 2b Clinical Trial 67 R Saizen R 67 Paliperidone ER 67 Talabostat 67 Is Well Tolerated 67 NAVISTAR R 67 Fluticasone 67 GW# [003] 67 insulin glulisine 67 steroid dexamethasone 67 rivastigmine Exelon 67 Velcade bortezomib 67 Arranon 67 EFFEXOR XR 67 Raptiva R 67 HER2 Positive Breast Cancer 67 baminercept 67 Mirapexin 67 COPAXONE R 67 Simulect 67 Initiates Phase III 67 Liprotamase 67 rilonacept 67 Tanespimycin 67 Schizophrenia Drug 66 BARACLUDE ® 66 Randomized Study 66 Systemic Sclerosis 66 lupus nephritis 66 Antidepressant Drug 66 ACE Inhibitor 66 Rheumatoid Arthritis RA 66 novel VDA molecule 66 Raptiva ® 66 Ofatumumab 66 TYKERB 66 Renal Function 66 erlotinib Tarceva ® 66 Oxaliplatin 66 Soriatane 66 Neulasta ® 66 Budesonide 66 Bronchodilator 66 Blood Pressure Drug 66 Pafuramidine 66 Quetiapine 66 Vidaza ® 66 Autoimmune Disease 66 Advanced Renal Cell 66 Diabetic Nephropathy 66 Gefitinib 66 APTIVUS 66 Chemoradiation 66 methylnaltrexone 66 herpetic keratitis 66 guanfacine extended release 66 Parathyroid Hormone 66 SomatoKine 66 E1 INT TM 66 FUSILEV enhances 66 dasatinib Sprycel ® 66 Betaferon ® 66 verteporfin 66 ACTEMRA 66 Clinical Efficacy 66 RAPAFLO 66 Panzem R 66 psoriatic arthritis PsA 66 oral dual endothelin 66 CYP#A# substrate 66 Firazyr 66 Cariprazine 66 Inhaled nitric oxide 66 Plecanatide 66 subependymal giant cell 66 lanreotide 66 Aptivus ® 66 Adjuvant Therapy 66 Clolar ® 66 Sapacitabine 66 Pazopanib 66 Riluzole 66 haloperidol Haldol 66 Elagolix 66 Dose Escalation 66 immunomodulatory agents 66 Pfizer Lyrica 66 Bendamustine 66 gastrointestinal stromal tumors GIST 66 Phase 2a Clinical Trial 66 abacavir Ziagen 66 BRIM2 66 CIMZIA TM certolizumab pegol 66 subcutaneously administered 66 Generalized Anxiety Disorder 66 angiotensin receptor blocker ARB 66 Hepatitis C Genotype 66 Peginterferon Alfa 2a 66 NovoRapid 66 Donepezil 66 Neupro R 66 Hepatocellular Carcinoma 66 induce orthostatic hypotension 66 Filgrastim 66 Venlafaxine 66 Sevelamer 66 Progressive Multifocal Leukoencephalopathy 66 Ambrisentan 66 polyarticular 66 palifermin 66 immunosuppressant drug 66 Salmeterol 66 Hemophilia B 66 Malignant Melanoma 66 calcineurin inhibitor 66 Intervention Effectiveness 66 Bivalirudin 66 SJIA 66 memantine HCl 66 Solid Tumors 66 Breast Cancer Recurrence 66 Previously Untreated 66 Antitumor 66 AVASTIN 66 Toremifene 66 ST Elevation Myocardial 66 receptor tyrosine kinase inhibitor 66 Bisphosphonate 66 Pfizer Sutent 66 FIRMAGON 66 abatacept Orencia 66 docetaxel Taxotere ® 66 octreotide acetate 66 Rivaroxaban 66 dasatinib Sprycel 66 INSPIRE Trial Phase III 66 DMARDS 66 Intravitreal 66 CHOP chemotherapy 66 salmeterol fluticasone 66 Forodesine HCl 66 trastuzumab Herceptin 66 protein tyrosine phosphatase 1B 66 angiotensin II receptor blocker 66 ritonavir boosted 66 Gleevec resistant 66 Trandolapril 66 R lenalidomide 66 Fluorouracil 66 Bupropion 66 alpha 2a 66 Glufosfamide 66 Glioblastoma Multiforme 66 IFN beta 66 Multiple Myeloma Patients 66 5 HT6 receptor 66 Pramipexole 66 pioglitazone HCl 66 metformin HCl 66 Enbrel Humira 66 Diabetic Macular Edema 66 Receptor Antagonists 66 Phe restricted diet 66 denileukin diftitox 66 Dalbavancin 66 FDA Approvals 66 Ocrelizumab 66 myelodysplastic myeloproliferative diseases 66 Glatiramer acetate 66 Arcalyst 66 Azathioprine 66 QVAR ® 66 TNF alpha inhibitor 66 DEXILANT 66 long acting bronchodilator 66 Darbepoetin Alfa 66 Vascugel 66 aspirin clopidogrel 66 idiopathic thrombocytopenic purpura ITP 66 Acute Heart Failure 66 Showed Significant 66 diarrhea predominant irritable 66 interferon beta 1b 66 Valvular Heart Disease 66 Catapres 66 acitretin 66 MEVACOR 66 decitabine 66 Lenocta 66 Renal Impairment 66 Adjunctive 66 arthritis PsA 66 Castration Resistant Prostate Cancer 66 Enbrel etanercept 66 Demonstrates Positive 66 biologic DMARD 66 Postmenopausal Osteoporosis 66 LHRH agonist 66 Celebrex celecoxib 66 sitaxsentan 66 acyclovir Lauriad R 66 Azacitidine 66 Vivaglobin 66 Chronic Hepatitis C 66 hyperphenylalaninemia HPA due 66 Tesamorelin 66 Pharmacokinetic Study 66 Antiplatelet 66 Preclinical Models 66 induced macular edema 66 Improved Survival 66 Chronic Hepatitis B 66 Equetro 66 Glioma 66 TYZEKA 66 Cell Lymphoma CTCL 66 Sanvar R 66 Remission Maintenance 66 erythematosus 66 Fibromyalgia Pain 66 Elotuzumab 66 Mylan Receives Approval 66 Metabolic Disorder 66 Gout Drug 66 Neovascular AMD 66 Prospective Randomized 66 Replacement Therapy 66 gabapentin Neurontin 66 ® lenalidomide 66 Enzyme Replacement Therapy 66 luteinizing hormone releasing 66 BENICAR 66 Cetrorelix 66 constipation OIC 66 serotonin norepinephrine reuptake inhibitor 66 Indacaterol 66 Doxil ® 66 etanercept 66 C1 Inhibitor 66 Placebo Controlled Study 66 intravesical infusion therapy 65 Tezampanel 65 Rebif ® 65 Atopic Dermatitis 65 Helicobacter pylori eradication 65 dopamine receptor agonist 65 anakinra 65 Tolerability 65 UCB Cimzia 65 refractory chronic lymphocytic 65 ISTODAX ® 65 fibromyalgia syndrome 65 recurrent glioblastoma multiforme 65 Medoxomil 65 REMINYL ® 65 ALVESCO R 65 uric acid lowering 65 Ropinirole 65 SNT MC# 65 Gamunex C 65 Demonstrates Significant 65 interferon gamma 1b 65 Corticosteroid 65 Silodosin 65 SUPPRELIN R LA 65 AA Amyloidosis 65 serum phosphate 65 brand ciclesonide HFA 65 Cholesterol Lowering Drug 65 sargramostim 65 Gastrointestinal Stromal Tumors 65 AMEVIVE 65 complement inhibitor eculizumab 65 LY# [003] 65 desvenlafaxine 65 Hepatic Encephalopathy 65 Navelbine ® 65 Exacerbations 65 sorafenib Nexavar 65 AGILECT R 65 Seasonal Allergic Rhinitis 65 nilotinib 65 Non Responders 65 leukopenia pancytopenia thrombocytopenia 65 Keppra ® 65 clobazam 65 TREDAPTIVE 65 Autologous Stem Cell Transplantation 65 IBS C 65 Partial Onset Seizures 65 Combination therapy 65 atypical hemolytic uremic syndrome 65 HuMax EGFr 65 paliperidone ER 65 FDA APPROVES 65 Controlled Trial 65 Carvedilol 65 Drug Candidate 65 Hypoactive Sexual Desire Disorder 65 AERIUS 65 Randomized Phase II 65 Acute Myeloid Leukemia 65 Female Sexual Arousal 65 Enzastaurin 65 immunosuppressives 65 XYOTAX TM 65 relapsing remitting MS RRMS 65 post herpetic neuralgia PHN 65 Hydroxyurea 65 Pediatric Patients 65 Methylphenidate 65 Isotretinoin 65 Hypertensive Patients 65 Erlotinib 65 cell lymphoma CTCL 65 Kuvan R 65 Rituxan rituximab 65 Ciclesonide 65 Mantle Cell Lymphoma 65 acute humoral rejection 65 Unfractionated Heparin 65 Granulocyte Colony Stimulating Factor 65 diabetic neuropathic pain 65 carbamazepine Tegretol 65 Hematological Malignancies 65 leukemia AML 65 Rheumatoid 65 Ticagrelor 65 Advanced Prostate Cancer 65 Herceptin trastuzumab 65 Cladribine 65 BARACLUDE R 65 ipratropium bromide 65 Oral Mucositis 65 rhIGF-I/rhIGFBP-3 65 GSK# [001] 65 adult chronic ITP 65 methylnaltrexone bromide 65 Patient Outcomes 65 NOXAFIL 65 xanthine oxidase inhibitor 65 Abbott HUMIRA 65 alteplase 65 Roflumilast 65 Aryplase 65 reuptake inhibitor 65 oral rivaroxaban 65 haematologic 65 BCG refractory carcinoma 65 pancreatic enzyme replacement 65 CINQUIL 65 venlafaxine Effexor 65 Metastatic Melanoma 65 CCX# B 65 Lansoprazole 65 Clinical Outcome 65 Elderly Patients 65 Schizophrenia Treatment 65 quetiapine fumarate 65 PEGINTRON TM 65 Sustained Release 65 Telbivudine 65 Initiates Clinical 65 Immunosuppression 65 Invasive Fungal Infections 65 Pralatrexate 65 Prophylactic Treatment 65 ATACAND 65 Levetiracetam 65 Androgen Deprivation Therapy 65 Vfend 65 Sporanox 65 Kinoid 65 Carbidopa 65 rheumatoid arthritis psoriatic arthritis 65 acetonide FA 65 Atypical Antipsychotics 65 ACIPHEX 65 SUTENT ® 65 Fast Track Status 65 Systemic Lupus Erythematosus 65 Chronic Prostatitis 65 Beta Blocker 65 GnRH agonist 65 Oral corticosteroids 65 Metastatic Renal Cell Carcinoma 65 mTOR mammalian target 65 peginterferon alfa 65 vildagliptin 65 Oral Cladribine 65 Trobalt 65 Actemra 65 Aortic Stenosis 65 Dacogen decitabine 65 Ramipril 65 noninfectious uveitis 65 Pivotal Phase 65 erlotinib Tarceva R 65 MAGE A3 ASCI 65 Combination REOLYSIN R 65 Wellmune WGP 65 JAK2 Inhibitor 65 ropinirole 65 immune thrombocytopenic purpura 65 overactive bladder syndrome 65 homozygous familial hypercholesterolemia 65 Glimepiride 65 Maribavir 65 Colorectal Cancer Patients 65 ZD# [001] 65 Paliperidone Palmitate 65 Reminyl galantamine 65 Allogeneic 65 Resistant Hypertension 65 evaluating tivozanib 65 Rasagiline 65 Advanced Colorectal Cancer 65 Bare Metal Stent 65 Novel Oral 65 Celecoxib 65 Bipolar Depression 65 tinidazole 65 Zebinix 65 Lymphocytic 65 seropositive patients 65 intranasal corticosteroid 65 Pegylated Liposomal Doxorubicin 65 Hycamtin 65 benign prostatic hypertrophy BPH 65 vWD 65 prucalopride 65 uricase 65 Amgen Enbrel 65 Transdermal Patch 65 LHON 65 Prostacyclin 65 teriflunomide 65 achieved CCyR 65 Combination Treatment 65 Nesiritide 65 Serdolect ® 65 Desvenlafaxine Succinate 65 Warfarin Coumadin 65 Mitoxantrone 65 Imiquimod 65 Heterozygous Familial Hypercholesterolemia 65 Therapy Improves 65 Tigecycline 65 psoriasis psoriatic arthritis 65 post herpetic neuralgia 65 Intravenous Formulation 65 rheumatoid arthritis RA psoriatic 65 primary hypercholesterolemia 65 SCIg 65 PRISTIQ 65 JAK2 enzyme 65 infusional 65 Dendritic Cells 65 Lacosamide 65 Fixed Dose 65 Leber Hereditary Optic Neuropathy 65 Glucocorticoid 65 Neupogen ® 65 Sandostatin LAR 65 HQK 65 Cognitive Deficits 65 Voreloxin 65 malignant ascites 65 RNAi Therapeutic 65 Tyrosine Kinase Inhibitors 65 CTAP# Capsules 65 C1 INH deficiency 65 Advanced Pancreatic Cancer 65 Pegylated Interferon 65 Pramlintide 65 HuMax CD4 65 topical calcineurin inhibitors 65 Romidepsin 65 Hycamtin ® 65 Toviaz 65 EXJADE 65 lacosamide 65 Orphan Designation 65 Tasimelteon 65 Crohn disease CD 65 HDAC Inhibitor 65 Randomized Double Blind 65 Antifungals 65 clozapine Clozaril 65 acetylcholinesterase inhibitor 65 Gleevec imatinib mesylate 65 pancreatic insufficiency 65 Receives Orphan Drug Designation 65 TNF alpha antagonist 65 Therapy Evaluation 65 myopathy rhabdomyolysis 65 Olanzapine 65 imatinib resistant 65 Chronic Bronchitis 65 abatacept 65 Etravirine 65 rheumatoid arthritis Crohn disease 65 pulmonary hypertension PH 65 Plicera 65 Psoriasis Patients 65 Acute Attacks 65 Esomeprazole 65 Osteoporosis Drug 65 Anti Tumor 65 eltrombopag 65 Thiazolidinediones 65 Cetuximab 65 First Patient Enrolled 65 romiplostim 65 Initiate Clinical Trial 65 Venous Thromboembolism 65 Namenda ® 65 Lung Cancer Drug 65 Cimzia ® 65 A1PI 65 bortezomib Velcade 65 PROMACTA 65 flecainide 65 alpha interferons 65 Victoza R 65 Genentech Rituxan 65 Prostate Cancer Vaccine 65 NOMID 65 Vidaza R 65 Microalbuminuria 65 Diuretic 65 SHPT 65 Migraine Pain 65 INVEGA ® 65 Candesartan 65 PRN FDA Approves 65 Ozarelix 65 Sitagliptin 65 imatinib Gleevec 65 SPRIX ® 64 Chronic Pelvic Pain 64 Anticancer Agent 64 Doripenem 64 CAELYX 64 REYATAZ R 64 Receptor Antagonist 64 NICE Recommends 64 Interferon Alpha 64 Skeletal Muscle 64 Trodusquemine MSI 64 Duloxetine 64 Escitalopram 64 Novel Mechanism 64 Enoxaparin 64 ziprasidone Geodon 64 Extended Release 64 Systemic Lupus Erythematosus SLE 64 AZILECT R 64 erlotinib Tarceva 64 Sodium oxybate 64 Interferon beta 1b 64 hormone LHRH antagonist 64 adriamycin 64 betamethasone dipropionate 64 pregabalin Lyrica 64 Gastric Cancer 64 pegylated liposomal doxorubicin 64 esophageal candidiasis 64 Hyperlipidemia 64 Known generically 64 receiving immunosuppressive therapy 64 Leukine 64 divalproex sodium 64 Campral 64 Rheumatoid Arthritis Drug 64 Lymphoid 64 Dabigatran 64 Receptor Agonist 64 Heart Failure Patients 64 epoetin beta 64 pouchitis 64 Mouse Model 64 moderate renal impairment 64 Telmisartan 64 Bronchial Thermoplasty 64 DFMO 64 Benazepril 64 Jevtana 64 Fungal Infections 64 Diffuse Large B 64 Clinical Trial Results 64 Psoriatic arthritis 64 FDA Okays 64 PEG interferon 64 Immunotherapeutic 64 zoledronate 64 MGd 64 APTIVUS r 64 DPNP 64 Therapy Reduces 64 clonidine hydrochloride 64 HUMIRA 64 Patients Suffering